Hasui, Nobuhiro
Sakaguchi, Katsuhisa
Ogawa, Tetsuya
Sakamoto, Yoshihiro
Shimizu, Tatsuya
Funding for this research was provided by:
CellSeed
Nihon kohden
EA Pharma Co., Ltd.
Article History
Received: 7 January 2022
Accepted: 17 March 2022
First Online: 29 March 2022
Competing interests
: T.S. is a stakeholder of CellSeed, Inc. T.O. is an employee of the Nihon Kohden Corporation. N.H., K.S., and Y.S. declare that they have no conflicts of interest.